Prognostic value of plasma markers of immune activation in patients with advanced HIV disease treated by combination antiretroviral therapy

Clinical Immunology

Volumn 99, Issue 3, 2001, Pages 347-352

  Saves M ^a   Morlat, P ^b   Chene G ^a   Peuchant, E ^b   Pellegrin, I ^c   Bonnet, F ^b   Bernard, N ^b   Lacoste, D ^b   Salamon, R ^a   Beylot, J ^b  

^a INSERM   (France)

^b HÔPITAL SAINT ANDRÉ   (France)

^c HÔPITAL PELLEGRIN   (France)

Author keywords

AIDS; Antiretroviral therapy; Clinical progression; Cytokines; HIV infection; Immune activation; STNFR II; 2 microglobulin

Indexed keywords

ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; BETA 2 MICROGLOBULIN; CYTOKINE; GAMMA INTERFERON; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; DISEASE COURSE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PLASMA; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; VIRUS INFECTION;

EID: 0035010038     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2001.5033     Document Type: Article

References (31)

1. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1
2. + lymphocyte count improves assessment of antiretroviral therapeutic response: ACTG Protocol Virology Substudy Team
3. + lymphocytes as prognostic markers of HIV-1 infection
4. The role of immunologic and viral markers in predicting clinical outcome in HIV infection
5. Seropositivity for HIV and the development of AIDS or AIDS related condition: Three year follow up of the San Francisco General Hospital cohort
6. Serum beta2-microglobulin level increases in HIV infection: Relation to seroconversion, CD4 T-cell fall and prognosis
7. Soluble receptors for tumor necrosis factor as predictors of progression to AIDS in asymptomatic human immunodeficiency virus type 1 infection
8. Serum HIV-RNA levels compared to soluble markers of immune activation to predict disease progression in HIV-infected individuals
9. 2 microglobulin
10. Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements
11. Increased serum concentrations of soluble tumor necrosis factor receptors in HIV-infected individuals are associated with immune activation
12. + cell counts of 200 per cubic millimeter or less
13. Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease
14. Effect of HAART on natural history of AIDS-related opportunistic disorders
15. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
16. 2-microglobulin and prediction of progression to AIDS in HIV infection
17. Immunological and serological markers predictive of progression to AIDS in a cohort of HIV-infected drug users
18. Markers for disease progression in intravenous drug users infected with HIV-1
19. Prognostic indicators for development of AIDS among intravenous drug users
20. Reduction of immune system activation in HIV-1 infected patients undergoing highly active antiretroviral therapy
21. Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: Persistent TNF activation is associated with virologic and immunologic treatment failure
22. Cytokines in HIV infection: Is AIDS a tumor necrosis factor disease?
23. Evaluation of measurement of human TNF in plasma by ELISA
24. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors
25. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists
26. Increased soluble tumor necrosis factor receptor expression and release by human immunodeficiency virus type 1 infection
27. Serum levels of tumor necrosis factor-α (TNFα) and soluble TNF receptors in human immunodeficiecy virus type 1 infection - Correlations to clinical, immunological and virologic parameters
28. Relationship of plasma HIV-RNA levels and levels of TNF-α and immune activation products in HIV infection
29. Interferon-γ concentrations are increased in sera from individuals infected with human immunodeficiency virus type 1
30. Soluble tumor necrosis factor-a receptor type II (sTNFαRII) correlates with human immunodeficiency virus (HIV) RNA copy number in HIV-infected patients